Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer

Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer

E Gabriela Chiorean,1 Daniel Von Hoff,2 Yin Wan,3 Sandra Margunato-Debay,4 Marc Botteman,3 David Goldstein5 1Medical Oncology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, 2Oncology, Translational Genomics Research Institute and HonorHealth, Phoenix, AZ, 3Pharmerit...

Full description

Bibliographic Details
Main Authors: Chiorean EG, Von Hoff D, Wan Y, Margunato-Debay S, Botteman M, Goldstein D
Format: Article
Language:English
Published: Dove Medical Press 2018-05-01
Series:Cancer Management and Research
Subjects:
Karnofsky performance status
metastatic pancreatic cancer
chemotherapy
nab-paclitaxel
gemcitabine.
Online Access:https://www.dovepress.com/performance-status-dynamics-during-treatment-with-nab-paclitaxel-plus--peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/performance-status-dynamics-during-treatment-with-nab-paclitaxel-plus--peer-reviewed-article-CMAR

Similar Items